FNCT Biotech

FNCT Biotech is a clinical-stage biotechnology company dedicated to the development of innovative functional cell therapies for the treatment of cancer and autoimmune disorders. The company leverages its proprietary FNC platform to design and manufacture next-generation CAR-T and TCR-T cell products that aim to improve efficacy and safety in challenging disease environments. Its lead programs target hematological malignancies and solid tumors, including gastric and pancreatic cancers, by addressing the limitations of current cell therapy approaches such as T-cell exhaustion. Headquartered in Suzhou, China, FNCT Biotech integrates research, development, and clinical translation to provide transformative solutions for patients worldwide. The company is supported by prominent venture capital investors and maintains a robust pipeline of clinical and preclinical candidates. Its approach focuses on metabolic reprogramming and functional enhancement of T cells to ensure better persistence and tumor infiltration.